---
title: "Quantum eMotion shareholders back director slate at annual meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290300521.md"
description: "Quantum eMotion shareholders approved a director slate, amended the stock option plan, and reappointed Richter LLP as auditor at their June 18, 2026 annual meeting. The board also authorized accelerated vesting of 125,000 stock options for former director Larry Moore, though execution remains unconfirmed."
datetime: "2026-06-19T15:12:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290300521.md)
  - [en](https://longbridge.com/en/news/290300521.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290300521.md)
generator: "portal-rs"
---

# Quantum eMotion shareholders back director slate at annual meeting

-   Quantum eMotion held its annual shareholder meeting on June 18, 2026. \* Shareholders adopted an amendment to the stock option plan. \* Shareholders ratified the reappointment of Richter LLP as auditor. \* The board authorized accelerated vesting of 125,000 stock options previously granted to consultant and former director Larry Moore; execution was not confirmed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum eMotion Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202606191111NEWSFILECNPR\_\_\_\_20260619\_302193\_1) on June 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [QNC.US](https://longbridge.com/en/quote/QNC.US.md)

## Related News & Research

- [Quantum eMotion Corp. GAAP EPS of $0.03, revenue of $12.06M](https://longbridge.com/en/news/296117893.md)
- [Quantum eMotion cites factors affecting financial and operating performance in Q2 ended June 30, 2026 MD&A](https://longbridge.com/en/news/295976988.md)
- [AI Stocks With Real Revenue From Enterprise Software and Cybersecurity](https://longbridge.com/en/news/296685105.md)
- [Quantum BioPharma GAAP EPS of -$0.47](https://longbridge.com/en/news/295931268.md)
- [Quantum BioPharma grants 572,500 stock options at C$ 4.8 each](https://longbridge.com/en/news/296658030.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**